Diagnamed Holdings Corp.

CNSX:DMED Stock Report

Market Cap: CA$2.0m

Diagnamed Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

CNSX:DMED Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Nov 24BuyCA$825Fabio ChianelliIndividual55,000CA$0.015
25 Nov 24BuyCA$750Fabio ChianelliIndividual50,000CA$0.015
22 Nov 24BuyCA$911Fabio ChianelliIndividual45,530CA$0.02
22 Nov 24BuyCA$1,000Fabiotech Inc.Company50,000CA$0.02
01 Nov 24BuyCA$525Fabio ChianelliIndividual21,000CA$0.025
01 Nov 24BuyCA$1,500Fabio ChianelliIndividual50,000CA$0.03
01 Nov 24BuyCA$100Fabio ChianelliIndividual4,000CA$0.025
30 Oct 24BuyCA$2,000Fabio ChianelliIndividual100,000CA$0.02
17 Sep 24BuyCA$630Fabio ChianelliIndividual126,000CA$0.005
01 Aug 24BuyCA$910Fabio ChianelliIndividual91,000CA$0.01
04 Jul 24BuyCA$800Fabio ChianelliIndividual40,000CA$0.02
25 Apr 24BuyCA$450Fabio ChianelliIndividual10,000CA$0.045
11 Apr 24BuyCA$2,250Fabio ChianelliIndividual75,000CA$0.03
18 Mar 24BuyCA$660Fabio ChianelliIndividual10,000CA$0.066
11 Mar 24BuyCA$782Fabio ChianelliIndividual22,330CA$0.035
04 Mar 24BuyCA$600Fabio ChianelliIndividual20,000CA$0.03
28 Feb 24BuyCA$300Fabio ChianelliIndividual10,000CA$0.03
28 Feb 24BuyCA$350Fabiotech Inc.Company10,000CA$0.035
28 Feb 24BuyCA$90Fabio ChianelliIndividual3,000CA$0.03
05 Feb 24BuyCA$650Fabio ChianelliIndividual20,000CA$0.032

Insider Trading Volume

Insider Buying: DMED insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of DMED?
Owner TypeNumber of SharesOwnership Percentage
Private Companies7,844,1779.8%
Individual Insiders9,949,17712.4%
General Public62,259,28677.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 3 shareholders own 22.23% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.93%
Fabio Chianelli
7,949,177CA$198.7k4.27%no data
9.8%
Fabiotech Inc.
7,844,177CA$196.1k4,030%no data
2.5%
Carlo Sansalone
2,000,000CA$50.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 08:13
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Diagnamed Holdings Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution